We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$97.7B
AUM Growth
-$4B
(-3.9%)
Cap. Flow
-$688M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,548
New
82
Increased
1,085
Reduced
1,201
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keysight
KEYS
|
+$304M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$298M |
| 3 |
Principal Financial Group
PFG
|
+$274M |
| 4 |
Raymond James Financial
RJF
|
+$274M |
| 5 |
Truist Financial
TFC
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$316M |
| 2 |
T. Rowe Price
TROW
|
+$273M |
| 3 |
SW
Smurfit Westrock
SW
|
+$271M |
| 4 |
BJs Wholesale Club
BJ
|
+$241M |
| 5 |
Icon
ICLR
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.08% |
| 2 | Financials | 13.89% |
| 3 | Consumer Discretionary | 11.29% |
| 4 | Industrials | 10.31% |
| 5 | Healthcare | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
BioMarin Pharmaceuticals
BMRN
$13.3B
| $4.96M | 0.01% |
70,234
-207,505
| -75% | -$14M |
|
1252
Protagonist Therapeutics
PTGX
$9.71B
| $4.95M | 0.01% |
102,411
-138,406
| -57% | -$5.8M |
|
1253
First Solar
FSLR
$25.7B
| $4.9M | 0.01% |
38,762
+2,519
| +7% | +$393K |
|
1254
Benchmark Electronics
BHE
$2.92B
| $4.88M | 0.01% |
128,281
+89,154
| +228% | +$3.76M |
|
1255
Commerce Bancshares
CBSH
$8.41B
| $4.88M | 0.01% |
82,280
-11,301
| -12% | -$688K |
|
1256
DraftKings
DKNG
$12B
| $4.86M | 0.01% |
146,431
+21,754
| +17% | +$894K |
|
1257
Alarm.com
ALRM
$2.77B
| $4.84M | 0.01% |
87,061
-1,332
| -2% | -$79.9K |
|
1258
M/I Homes
MHO
$3.74B
| $4.82M | ﹤0.01% |
42,221
-4,828
| -10% | -$593K |
|
1259
Erie Indemnity
ERIE
$13.2B
| $4.79M | ﹤0.01% |
11,421
+567
| +5% | +$231K |
|
1260
Estee Lauder
EL
$31.5B
| $4.77M | ﹤0.01% |
72,277
-83,897
| -54% | -$6.07M |
|
1261
UL Solutions
ULS
$15.8B
| $4.77M | ﹤0.01% |
84,558
+53,195
| +170% | +$2.82M |
|
1262
StoneX
SNEX
$7.81B
| $4.77M | ﹤0.01% |
140,391
+97,444
| +227% | +$3.27M |
|
1263
Enova International
ENVA
$6.29B
| $4.77M | ﹤0.01% |
49,352
+18,144
| +58% | +$1.87M |
|
1264
MillerKnoll
MLKN
$1.64B
| $4.76M | ﹤0.01% |
248,518
-27,430
| -10% | -$583K |
|
|
AL
1265
DELISTED
Air Lease Corp
AL
| $4.74M | ﹤0.01% |
98,214
+44,259
| +82% | +$2.08M |
|
1266
Argan
AGX
$8.15B
| $4.74M | ﹤0.01% |
36,124
+18,609
| +106% | +$2.6M |
|
1267
Alight
ALIT
$394M
| $4.73M | ﹤0.01% |
39,910
-295,569
| -88% | -$38.9M |
|
1268
Birkenstock
BIRK
$7.3B
| $4.72M | ﹤0.01% |
102,900
-279,415
| -73% | -$14.7M |
|
|
APLS
1269
DELISTED
Apellis Pharmaceuticals
APLS
| $4.71M | ﹤0.01% |
215,152
-347,117
| -62% | -$9.59M |
|
1270
Bread Financial
BFH
$4.38B
| $4.67M | ﹤0.01% |
93,207
+27,919
| +43% | +$1.59M |
|
|
KLG
1271
DELISTED
WK Kellogg Co
KLG
| $4.66M | ﹤0.01% |
233,735
-262
| -0.1% | -$4.78K |
|
1272
Thor Industries
THO
$4.14B
| $4.66M | ﹤0.01% |
61,408
+301
| +0.5% | +$28.3K |
|
1273
Abercrombie & Fitch
ANF
$5.27B
| $4.64M | ﹤0.01% |
60,810
+35,443
| +140% | +$3.82M |
|
1274
Moelis & Co
MC
$4.72B
| $4.64M | ﹤0.01% |
79,427
-6,438
| -7% | -$454K |
|
1275
Arrow Electronics
ARW
$10.3B
| $4.61M | ﹤0.01% |
44,398
+23,729
| +115% | +$2.62M |
|
Similar funds
VGA
Victory Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Victory Capital Management held 2,548 positions worth $97.7B, down 3.9% from $102B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Victory Capital Management's Q1 2025 filing shows 82 new, 1,085 increased, 1,201 reduced and 79 closed positions. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 5,316,622 shares worth $293M. The largest sale was Target, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Victory Capital Management's largest Q1 2025 buy was iShares MSCI Emerging Markets ex China ETF: 5,316,622 shares worth $293M.
- Victory Capital Management added most to Keysight in Q1 2025, an estimated $304M increase.
- Victory Capital Management's biggest Q1 2025 reduction was Target, cutting an estimated $316M.
- Victory Capital Management fully exited Icon in Q1 2025, selling an estimated $222M.
- Victory Capital Management's ten largest holdings make up 13% of its $97.7B portfolio in Q1 2025.
- Victory Capital Management opened 82 new positions and closed 79 in Q1 2025.
- Victory Capital Management's portfolio value fell 3.9% quarter-over-quarter to $97.7B.
Based on Victory Capital Management's 13F filing for Q1 2025, filed 2 May 2025.